Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immuno
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), an immuno-oncology company developing...
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immuno
BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-33
Indigo Agriculture and Anheuser-Busch Partner To Meet Sustainability Goals for Rice Production
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs
Gossamer Bio pulls off $276M IPO to push a trio of programs through the clinic
Indigo Agriculture Launches Indigo Transport™, a Digital Logistics Platform to Expand Options for Gr
BlackThorn Therapeutics Announces R&D Updates
Indigo Ag, Inc. Acquires TellusLabs, a Leader in Satellite Technology and Artificial Intelligence, t
Millendo Therapeutics Announces Successful Merger Completion